Disease Detection Suppliers Serving Seychelles

LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary ...

Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, ...

Viz.ai was inspired by a patient who underwent a successful brain surgery and yet died because the surgery came too late. Systemic “ but preventable“ process delays had undermined the work of her care team. Frustrated by the unnecessary delays that ...

With a heritage of over a hundred years, Sveaverken Svea Agri AB has a long tradition of driving innovations in the farming and husbandry sectors in the Nordic region. Today, Sveaverken is devoted to transforming the traditional agriculture industry ...

Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...

C₂N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent or stop the progression of human neurological disorders. Diagnostic efforts revolve around ...

Cercare Medical is based on +25 years of research in perfusion imaging and artificial intelligence. Our novel biomarkers provide unparalleled patient insights. We are bridging the gap between science and clinical practice. With our amazing ...

We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to ...

Guided Therapeutics, Inc. (OTC: QB GTHP) is committed to developing groundbreaking medical devices using our patented biophotonic technology to detect diseases earlier, more accurately, and more efficiently than other tests. Since Guided ...

At lifespin, we digitize biological samples. We create the connection of “life” to the possibilities of the information age. We record very many metabolites simultaneously in one measurement and thus create a “fingerprint” of a person or an organism ...

Bio-Me is Setting the Standard for Routine Microbiome Analysis. Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our ...

LumiQuick Diagnostics Inc., located in the heart of Silicon Valley, California, USA, develops, manufactures and markets high quality point of care tests and other immunoassay kits for the world-wide In vitro diagnostic market. Through years of ...

Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...

Cardiowise connects cardiac CT data with innovative new artificial intelligence (AI) algorithms that augment human decision-making within existing clinical workflows. An accurate diagnosis is the first step to preventing heart disease. CardioWise's ...

DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...

Zomedica is dedicated to empowering clinical veterinarians by delivering advanced and effective products and services that enhance both patient and practice health. Their mission focuses on augmenting veterinary practitioners' capabilities through a ...

Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...

INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...

Perspectum delivers cutting-edge digital technologies that help clinicians provide better care for patients with liver disease, diabetes, and cancer. With a strong focus on precision medicine using advanced imaging and genetics, our vision is to ...

betaSENSE is transforming the landscape of protein diagnostics by focusing on the early detection of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Emerging from pioneering research at Ruhr University Bochum, led by Prof. Dr. Klaus ...